Odyssey Therapeutics Inc (ODTX)

Panoramica Notizia Cronologia dei prezzi Financials Forum Previsione

Odyssey Therapeutics Inc Azioni (ODTX) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2026-06-30	2026-03-31
Durata del periodo	3 mesi	3 mesi
Revenues	-	-
Operating Expenses	39.44% 55.47	39.78
Operating Income/Loss	39.44% -55.47	-39.78
Nonoperating Income/Loss	69.13% 2.674	1.581
Income/Loss From Continuing Operations Before Tax	38.21% -52.80	-38.20
Income Tax Expense/Benefit	112.70% -0.008	0.063
Net Income/Loss	37.96% -52.79	-38.26
Basic Average Shares	435.34% 30.28	5.6557
Diluted Average Shares	435.34% 30.28	5.6557
Basic Earnings Per Share	74.30% -1.74	-6.77
Diluted Earnings Per Share	74.30% -1.74	-6.77

AVBP

$16.66

0.77%

GLUE

$9.74

3.75%

CGEM

$12.93

7.64%

ABUS

$4.22

1.63%

MLTX

$9.55

6.92%

AKTS

$15.06

5.93%